Disease management and the drug industry: Carve out or carve up?

Lancet

Volumn 347, Issue 9007, 1996, Pages 1021-1023

  Burns, Harry ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; HEALTH CARE DELIVERY; HUMAN; POLICY; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM;

EID: 0029986034     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90151-8     Document Type: Article

References (4)

1. Zalta E, Eichner H, Henry M. Implication of disease management in the future of managed care. Med Interface 1994; 7: 66-68, 78.
2. Commercial approaches to the NHS regarding disease management packages. London: NHS Executive, EL(94)94, 1994.
3. Hunter D. Panacea or placebo? Hlth Service J 1995; Oct 5: 22-24.
4. Boston Consulting Group. The promise of disease management. Boston: Boston Consulting Group, 1995: 15.